Enzon Pharmaceuticals (ENZN) Financial Statements

Enzon Pharmaceuticals's market cap is currently $3.90M. The company's EPS TTM is $-0.006; its P/E ratio is -1.48; Enzon Pharmaceuticals is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.